Jun 8, 2020
|
Ardelyx Appoints Veteran Biopharma Executive, Justin Renz, as Chief Financial Officer
|
May 26, 2020
|
Ardelyx to Present at the Jefferies 2020 Virtual Healthcare Conference
|
May 21, 2020
|
Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
May 18, 2020
|
Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial Officer
|
May 7, 2020
|
Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights
|
Mar 16, 2020
|
Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors
|
Mar 6, 2020
|
Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
|
Feb 26, 2020
|
Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference
|
Feb 19, 2020
|
Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference
|
Dec 4, 2019
|
Ardelyx Announces Pricing of Upsized Public Offering of Common Stock
|